News

Computerized systems reduce risk of VTE, analysis suggests


 

Team performing surgery Photo by Piotr Bodzek Photo by Piotr Bodzek

Team performing surgery

The use of computerized clinical decision support systems can reduce the risk of venous thromboembolism (VTE) among surgical patients, according to new research.

Results of a review and meta-analysis showed that use of these computerized systems was associated with a significant increase in the proportion of surgical patients with adequate VTE prophylaxis and a significant decrease in the patients’ risk of developing VTE.

Zachary M. Borab, of the New York University School of Medicine in New York, New York, and his colleagues reported these findings in JAMA Surgery.

A computerized clinical decision support system is rule­ or algorithm-based software that can be integrated into an electronic health record and uses data to present evidence-based knowledge at the individual patient level.

Borab and his colleagues conducted a review and meta-analysis to assess the effect of such systems on increasing adherence to VTE prophylaxis guidelines and decreasing post-operative VTEs, when compared with routine care.

The researchers combed through several databases looking for studies of surgical patients in which investigators compared routine care to computerized clinical decision support systems with VTE risk stratification and assistance in ordering VTE prophylaxis.

The team found 11 studies that were eligible for meta-analysis—9 prospective and 2 retrospective trials. The trials included a total of 156,366 patients—104,241 in the computerized clinical decision support systems group and 52,125 in the control group.

Analysis of these data revealed that using the computerized systems was associated with a significant increase in the rate of appropriate ordering of VTE prophylaxis. The odds ratio was 2.35 (95% CI, 1.78-3.10; P<0.001).

Use of the computerized systems was also associated with a significant decrease in the risk of VTE. The risk ratio was 0.78 (95% CI, 0.72-0.85; P<0.001).

Based on these results, Borab and his colleagues concluded that computerized clinical decision support systems should be used to help clinicians assess the risk of VTE and provide the appropriate prophylaxis in surgical patients.

Recommended Reading

Recent increase in subdural hematoma may be linked to antithrombotics
MDedge Hematology and Oncology
Ticagrelor improves platelet reactivity, but not clinical outcomes, in Chinese stroke patients
MDedge Hematology and Oncology
Stroke in AF patients often preceded by inadequate anticoagulation
MDedge Hematology and Oncology
Death risks associated with long-term DAPT
MDedge Hematology and Oncology
‘Inadequate’ anticoagulation found in AFib patients with stroke
MDedge Hematology and Oncology
Long-term safety, efficacy of hemophilia B therapy
MDedge Hematology and Oncology
Hemophilia B therapy granted access to PRIME program
MDedge Hematology and Oncology
FDA approves new unit for clot-dissolving device
MDedge Hematology and Oncology
Antithrombotic drugs may raise risk of subdural hematoma
MDedge Hematology and Oncology
Hemophilia repository open to US scientists
MDedge Hematology and Oncology